Chimeric Antigen Receptor T-Cell Manufacturing Turnaround: Vein-to-Vein Time as a Clinical Variable. (2023). Translational Medicine & Therapeutics Journal, 2(1), 1-9. https://doi.org/10.5281/zenodo.22649019